SureTrader
Home > Boards > US Listed > Biotechs > Intellipharmaceutics International Inc. (IPCI)

Fred- Since the growth has stalled, I am

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
wimuskyfisherman Member Profile
 
Followed By 5
Posts 1,249
Boards Moderated 0
Alias Born 11/26/14
160x600 placeholder
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/16/2018 6:32:05 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/14/2018 11:13:52 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/14/2018 6:54:36 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 2/9/2018 8:08:58 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 1/24/2018 8:04:28 AM
Intellipharmaceutics Provides Operational Update GlobeNewswire Inc. - 1/24/2018 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 12/5/2017 8:05:20 AM
Intellipharmaceutics Announces Receipt of Nasdaq Notice GlobeNewswire Inc. - 12/5/2017 8:00:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 12/4/2017 5:21:01 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 11/30/2017 10:51:14 AM
Intellipharmaceutics Reports on Launch of Additional Strengths of Generic Focalin XR® by Par Pharmaceutical GlobeNewswire Inc. - 11/30/2017 10:45:00 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/20/2017 5:20:34 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 10/18/2017 3:20:22 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/16/2017 6:03:43 AM
Intellipharmaceutics Announces Closing of US$4 Million Financing GlobeNewswire Inc. - 10/13/2017 5:45:00 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/13/2017 6:04:15 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/12/2017 4:07:48 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/11/2017 8:07:45 AM
Intellipharmaceutics Announces US$4 Million Registered Direct Offering GlobeNewswire Inc. - 10/11/2017 8:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 10/10/2017 5:25:56 PM
Intellipharmaceutics Announces Third Quarter 2017 Results GlobeNewswire Inc. - 10/10/2017 5:20:59 PM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/25/2017 7:12:00 AM
Intellipharmaceutics Receives Complete Response Letter from the FDA for Rexista™ NDA GlobeNewswire Inc. - 9/25/2017 7:00:00 AM
Report of Foreign Issuer (6-k) Edgar (US Regulatory) - 9/20/2017 5:18:47 PM
Intellipharmaceutics Announces Receipt of Nasdaq Notice GlobeNewswire Inc. - 9/20/2017 5:10:00 PM
wimuskyfisherman   Friday, 11/10/17 01:02:02 PM
Re: fred198484 post# 31185
Post # of 32844 
Fred- Since the growth has stalled, I am thinking we don't see an uptick until MNK can get a chance to bid on some of the orders that were locked up prior to MNK getting the product released.

Q4 is going to be disappointing for sure. My rough guess now is we might see $2M total revenue absolute tops.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist